Kroon, M E <br/><br/>
Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix.  [electronic resource] 

 -  Blood  Oct 2000 
 - 2775-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD--biosynthesis<br/>Cell Hypoxia<br/>Cell Survival<br/>Cells, Cultured<br/>Culture Media<br/>Culture Media, Conditioned<br/>DNA, Complementary--genetics<br/>Endothelial Growth Factors--pharmacology<br/>Endothelium, Vascular--cytology<br/>Extracellular Matrix<br/>Fibrin<br/>Fibrinolysin--physiology<br/>Fibroblast Growth Factor 2--pharmacology<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Hypoxia--physiopathology<br/>Integrin alphaV<br/>Integrins--antagonists & inhibitors<br/>Lymphokines--pharmacology<br/>Morphogenesis--physiology<br/>Neovascularization, Pathologic--physiopathology<br/>Oxygen--pharmacology<br/>Proto-Oncogene Proteins--physiology<br/>RNA, Messenger--biosynthesis<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Receptors, Cell Surface--biosynthesis<br/>Receptors, Growth Factor--antagonists & inhibitors<br/>Receptors, Urokinase Plasminogen Activator<br/>Receptors, Vascular Endothelial Growth Factor<br/>Receptors, Vitronectin--antagonists & inhibitors<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>Urokinase-Type Plasminogen Activator--physiology<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factor Receptor-1<br/>Vascular Endothelial Growth Factors